Swiss pharma giant Novartis’ has announced results showing that one in four patients with hormone receptor-positive, human ...

The US regulator has approved Waskyra (etuvetidigene autotemcel), the first gene-correcting therapy for Wiskott-Aldrich ...

Headquartered in Antwerp, Belgium, with an additional site in Denmark (Aarhus). The company is developing macrophage-targeted ...

The US Food and Drug Administration has approved a US-manufactured version of Augmentin XR (amoxicillin-clavulanate potassium) through its new Commissioner’s National Priority Voucher pilot, ...

The US Food and Drug Administration (FDA) yesterday issued the final guidance, “Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Products, and ...

Vinay Prasad, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), ...

Switzerland’s Idorsia (SIX: IDIA) announced the publication of a new analysis from the landmark Phase III PRECISION study in Hypertension titled “Aprocitentan in Patients with Chronic Kidney Disease ...

The European Commission has approved Roche’s Gazyva/Gazyvaro (obinutuzumab) in combination with mycophenolate mofetil (MMF) ...

Generic drugmakers in India are revising pricing plans after Denmark’s Novo Nordisk (NOV: N) slashed costs for its weight-loss injection Wegovy (semaglutide). Companies that had aimed to launch ...

GSK (LSE: GSK) has chosen to unwind its synthetic lethality alliance with US biotech Ideaya Biosciences (Nasdaq: IDYA), ...

Privately-held UK biotech Relation Therapeutics has announced a multi-program, strategic collaboration with Swiss pharma giant Novartis to discover and advance novel targets for atopic diseases.

Sanegene Bio has raised more than $110 million in a series B round to move its RNAi programs toward registration studies and ...